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P U B L I S H E D B Y E L S E V I E R I N C .LETTERS TO THE EDITOROCT Visualization of the Structure of Intimal
Tissue After Drug-Eluting Balloon DeploymentThe drug-eluting balloon (DEB) is a device that is used to
reduce the risk of repeat stent implantation in patients
with in-stent restenosis (ISR) (1). Characterization of
tissue by optical coherence tomography (OCT) may
provide useful information to identify good candidates
for DEBs (2). However, the image visualized by OCT
just after DEB dilation is unclear. We present images
after DEB dilation visualized by OCT.
A 45-year-old man was treated with a bare metal
stent (BMS) (S-stent 4.0/23.0 mm) implanted in theFIGURE 1 OCT Imaging in an In Vivo Setting
Optical coherence tomography (OCT) imaging of in-stent restenosis (ISR
(PCI). (A) OCT imaging of ISR lesion before repeat PCI. (B) Just after La
deployment. (D to I) High-power ﬁeld images: high-intensity superﬁcial
seen on the endothelium were not present before PCI. These structuresright coronary artery (RCA) for acute ST-segment
elevation myocardial infarction. After percutaneous
coronary intervention (PCI), he was taking 100 mg of
aspirin and 75 mg of clopidogrel. However, a second
coronary angiography at 6 months after BMS implan-
tation showed ISR in the BMS. A repeat PCI was per-
formed for ISR in the RCA. After the guide wire was
advanced to the distal portion of the RCA, the target
lesion was dilated using a 4.0/13.0 mm scoring balloon
catheter (Lacrosse nonslip element [NSE] balloon,
Goodman Company, Ltd., Nagoya, Japan). After NSE
dilation, the target lesion was dilated using a 4.0/20.0
mm DEB system (SeQuent Please, B. Braun, Melsun-
gen, Germany and NIPRO Corporation, Osaka, Japan).
OCT was performed to evaluate ISR before (Figure 1A),
just after NSE dilation (Figure 1B), and DEB (Figure 1C).
OCT catheter was used with a Dragonﬂy JP image) lesion before and after repeat percutaneous coronary intervention
crosse nonslip element dilation. (C) Just after drug-eluting balloon
regions (yellow arrows) were visualized by OCT, and the structures
were distinct from the stent strut.
Letters to the Editor J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 8 , 2 0 1 5
A U G U S T 2 0 1 5 : 9 8 3 – 9
984catheter (St. Jude Medical, Westford, Massachusetts).
OCT demonstrated high-intensity superﬁcial regions
of the intimal tissue with intensity attenuation (not
stent strut) after DEB dilation (Figures 1D to 1I).
The high-intensity superﬁcial regions are thought
to represent an iopromide/paclitaxel mixture because
SeQuent Please uses the contrast medium iopromide
to separate and evenly distribute paclitaxel molecules
over the surface of the balloon.
After the PCI procedure, we assessed whether the
contrastmedia could be visualized byOCT in an in vitro
setting using the same system. We performed OCT on
a surgical grove that was wet with contrast medium
iomeprol, with a glove with dried contrast medium on
the surface, and a glove without contrast medium.
We conﬁrmed similar high-intensity superﬁcial
regions due to dry contrast medium smeared on the
surgical glove visualized by OCT. However, we could
not visualize high-intensity superﬁcial regions with
wet contrast medium or without contrast media.
Further studies are required to determine whether
these areas do indeed represent iopromide and/or
paclitaxel because we do not know with certainty the
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Active Reversible Disease in Human
Breast ArteriesMedial arterial calciﬁcation (MAC) is currently gaining
interest as a possible cause of cardiovascular diseasedistinct from atherosclerosis (1). Because MAC is
actively regulated by processes bearing great
similarities to the dynamic process of bone
formation, reversibility of MAC can be expected (1).
Although regression has been observed in animal
models, surprisingly limited observations of MAC
regression in humans are available. Currently none
of the cardiovascular medications has convincingly
been shown to modify arterial calciﬁcation.
Breast arterial calciﬁcation (BAC) is a type of MAC
regularly observed in mammography. In breast cancer
screening programs, these arteries are visualized re-
peatedly in a highly systematic fashion in the general
population. BAC can therefore serve as a convenient
model for MAC. BAC was found to be independently
associated with amoderately increased cardiovascular
disease risk in the general population (2). A few cases of
BAC regression have been reported (3). The extent to
which BAC regression occurs remains unknown.
We hypothesized that BAC regression would be
present in a population of women participating in
breast cancer screening. From August 1, 1998, to
January 31, 1999, we screened 32,589 women by
mammography within the Utrecht area in the
Netherlands. After approval was obtained from the
institutional review board of the University Medical
Center Utrecht, the mammograms of these women
were systematically investigated for BAC by 1 of 2
board-certiﬁed radiologists. If BAC was present, the
index mammogram was retrospectively compared
with previous mammograms, if available. Regression
was deﬁned as a decrease of arterial calciﬁcation
in at least 1 segment of an artery compared with
previous mammograms, as illustrated in Figure 1. To
determine whether regression had occurred, both
radiologists assessed the mammograms and resolved
disagreements in consensus meetings.
At least 1 previous mammogram was available for
25,296 women; of these, 2,948 (11.8%) had BAC in at
least 1 breast on the index mammogram. Among these
2,948 women with BAC, the BAC had regressed in
98 women (3.3%; 95% conﬁdence interval: 2.7 to 4.0).
All women with regression of BAC were sent a ques-
tionnaire regarding their medical history and cardio-
vascular risk factors. The 43 women (44%) who
completed the questionnaire were on average 72.5
years of age with a body mass index of 25.5 kg/m2.
Cardiovascular risk factors were common: 34.9% cur-
rent or previous smokers, 37.2% with hypertension,
36.6% with hypercholesterolemia, 14.6% with dia-
betes, and 11.9%with renal disease. Although no direct
comparison is possible, the characteristics of these
women appear comparable to those of women with
BAC described in published reports (2). Regression of
